[13C6]-Dexlansoprazole is a stable isotope labeled version of dexlansoprazole, a proton pump inhibitor used in the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. The stable isotope labeling allows for accurate pharmacokinetic and metabolic studies of the drug in humans and animals.
Chemically, [13C6]-Dexlansoprazole is a derivative of lansoprazole, which inhibits the H+/K+-ATPase proton pump in the parietal cells of the stomach, leading to a reduction in the production of gastric acid. The addition of six carbon-13 isotopes to the dexlansoprazole molecule allows for the drug to be tracked and quantified in biological samples using mass spectrometry.
The usage of [13C6]-Dexlansoprazole in pharmacokinetic studies provides valuable information on the absorption, distribution, metabolism, and excretion of the drug in vivo. It also allows for the determination of drug-drug interactions and the effects of food on the pharmacokinetics of dexlansoprazole.
In conclusion, [13C6]-Dexlansoprazole is a useful tool for researchers and clinicians in the field of gastroenterology, providing valuable insights into the pharmacokinetics of dexlansoprazole and aiding in the development of new treatment strategies for GERD and other gastrointestinal disorders.